The European Medicines Agency (EMA) gave its verdict, on Tuesday 20 April, on the Covid-19 vaccine produced by Johnson & Johnson: unusual thrombosis with low blood platelets should be included in the list of very rare side effects associated with this vaccine.
This is similar to the verdict given earlier this month for the AstraZeneca vaccine (see EUROPE B12693A1). As with AstraZeneca, the benefits outweigh the identified risks, the European Agency insists.
The agency’s executive...